Search results
Should the US forgive medical debt? Americans sound off in recent poll
FOX 10 Phoenix· 3 days agoThe poll was conducted by the University of Chicago Harris School of Public Policy and The...
Late-breaking results show nipocalimab significantly improves Sjögren's disease activity in a Phase...
FOX 23 News Albany· 6 days agoJohnson & Johnson (NYSE: JNJ) announces patients treated with nipocalimab demonstrated statistically...
Cabaletta Bio (NASDAQ:CABA) Shares Gap Up to $12.56
ETF DAILY NEWS· 7 days agoCabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $12.56, but opened at $13.35. Cabaletta Bio shares last ...
Why many women have heart health issues
Rolling Out· 5 days agoHeart health issues are a significant concern for women worldwide, yet they often go unnoticed and untreated. This article delves into why many women...
Citi maintains Buy rating on Cabaletta Bio post-EULAR data By Investing.com
Investing.com· 4 days agoOn Monday, Citi reaffirmed its positive stance on Cabaletta Bio Inc . The endorsement follows the...
Research Analysts Set Expectations for argenx SE’s Q2 2025 Earnings (NASDAQ:ARGX)
ETF DAILY NEWS· 3 days agoargenx SE (NASDAQ:ARGX – Free Report) – Equities research analysts at Wedbush lowered their Q2 2025 earnings per share (EPS) estimates for argenx in a research note issued to investors on Monday ...
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 3.9%
ETF DAILY NEWS· 5 days agoAurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) rose 3.9% on Friday . The stock traded as high as $5.60 and last traded at $5.56. Approximately 1,389,155 shares traded ...
Sierra Summit Advisors LLC Acquires New Shares in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
ETF DAILY NEWS· 5 days agoSierra Summit Advisors LLC acquired a new stake in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) during the fourth quarter, Holdings Channel reports. The fund acquired 22,436 ...
Cartesian Therapeutics (NASDAQ:RNAC) Receives “Outperform” Rating from Oppenheimer
ETF DAILY NEWS· 6 days agoOppenheimer restated their outperform rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a report issued on Friday, Benzinga reports. They currently have a $50.00 price ...
Q32 Bio (NASDAQ:QTTB) Receives New Coverage from Analysts at Guggenheim
ETF DAILY NEWS· 3 days agoGuggenheim assumed coverage on shares of Q32 Bio (NASDAQ:QTTB – Free Report) in a research report released on Monday, Marketbeat reports. The firm issued a buy rating and a $100.00 target price ...
